Monoamine Oxidase Inhibitors (MAOIs) are not as frequently used as SSRI's or TCA's due to the danger of dietary and drug interactions
Patients who respond best to MAOIs are : phobic and depressed patients with atypical, hypochondriacal or hysterical features
Withdrawal: Where possible, MAOIs should be withdrawn gradually withdrawal symptoms are experienced with MAOIs on cessation of treatment
Withdrawal symptoms include:
-
Agitation
-
Irritability
-
Ataxia
-
Insomnia
-
Drowsiness
-
Vivid dreams
-
Slowed speech
-
Occassionally: hallucinations and paranoid delusions
In the case of phenelzine, isorcarboxazid and or tranylcypromine they increase the risk of neonatal malformations during pregnancy
​Non-reversible monoamine oxidase inhibitors e.g. phenelzine are usually only prescribed by specialist mental health professionals
Tyramine is present in the following foods:
-
Mature cheese
-
Pickled herring
-
Broad bean pods
-
Bovril®
-
Oxo®
-
Marmite®
-
Or similar Meat or yeast extract
-
Fermented soya bean extract
The document titled "Focus on MAOIs" provides information of each drug within the MAOIs class. Click on the document below to learn about:
-
Adverse effects
-
Cautions
-
Contra-indications
-
Drug interactions
-
Cost amongst other important prescribing considerations